eISSN: 2299-0046
ISSN: 1642-395X
Advances in Dermatology and Allergology/Postępy Dermatologii i Alergologii
Current issue Archive Manuscripts accepted About the journal Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
Search
Editorial Policies
Sarajevo Declaration on Integrity and Visibility of Scholarly Publications
6/2024
vol. 41
 
Share:
Send email
Share:
Original paper

Impact of ozone concentration on the treatment effectiveness of diabetic foot syndrome: a pilot single-centre study

Jarosław Pasek
1
,
Sebastian Szajkowski
2
,
Dominika Rokicka
3
,
Marta Wróbel
3
,
Valter Travagli
4
,
Grzegorz Cieślar
5

  1. Władysław Biegański Collegium Medicum, Jan Długosz University, Częstochowa, Poland
  2. Faculty of Medical and Social Sciences, Warsaw Medical Academy of Applied Sciences, Warsaw, Poland
  3. Department of Internal Diseases, Diabetology, and Cardiometabolic Diseases, School of Medicine with the Division of Dentistry in Zabrze, Medical University of Silesia in Katowice, Silesian Centre for Heart Diseases in Zabrze, Poland
  4. Department of Biotechnology, Chemistry and Pharmacy, Siena, Italy
  5. Department of Internal Medicine, Angiology and Physical Medicine in Bytom, Faculty of Medical Sciences in Zabrze, Medical University of Silesia in Katowice, Poland
Adv Dermatol Allergol 2024; XLI (6): 626-633
DOI: https://doi.org/10.5114/ada.2024.145477
Online publish date: 2024/12/24
Article file
- Impact (1).pdf  [0.18 MB]
Get citation
 
 
1. van Netten JJ, Bus SA, Apelqvist J, et al. International Working Group on the Diabetic Foot. Definitions and criteria for diabetic foot disease. Diabetes Metab Res Rev 2020; 36: e3268.
2. Zhang P, Lu J, Jing Y, et al. Global epidemiology of diabetic foot ulceration: a systematic review and meta-analysis. Ann Med 2017; 49(2): 106-16.
3. The Diabetic Foot Brussels, Belgium, International Diabetes Federation, 2020. Accessed 1 August 2022. Available from https://www.idf.org/our-activities/care-prevention/diabetic-foot.html
4. Kleibert M, Mrozikiewicz-Rakowska B, Bąk PM, et al. Breakdown of diabetic foot ulcer care during the first year of the pandemic in Poland: a retrospective national cohort study. Int J Environ Res Public Health 2022; 19: 3827.
5. Bakker K, Apelqvist J, Lipsky BA, et al. International Working Group on the Diabetic Foot. International Working Group on the Diabetic Foot. The 2015 IWGDF guidance documents on prevention and management of foot problems in diabetes: development of an evidence-based global consensus. Diabetes Metab Res Rev 2016; 32 Suppl 1: 2-6.
6. Meloni M, Izzo V, Giurato L, et al. Prevalence, clinical aspects and outcomes in a large cohort of persons with diabetic foot disease: comparison between neuropathic and ischemic ulcers. J Clin Med 2020; 9: 1780.
7. Hoffstad O, Mitra N, Walsh J, et al. Diabetes, lower-extremity amputation, and death. Diabetes Care 2015; 38: 1852-7.
8. Chamberlain RC, Fleetwood K, Wild SH, et al. Foot ulcer and risk of lower limb amputation or death in people with diabetes: a national population-based retrospective cohort study. Diabetes Care 2022; 45: 83-91.
9. McDermott K, Fang M, Boulton A, et al. Etiology, epidemiology and disparities in the burden of diabetic foot ulcers. Diabetes Care 2023; 46: 209-21.
10. Game F. Classification of diabetic foot ulcers. Diabetes Metab Res Rev 2016; 32 (Suppl. 1): 186-94.
11. Brownrigg JR, Schaper NC, Hinchliffe RJ. Diagnosis and assessment of peripheral arterial disease in the diabetic foot. Diabet Med 2015; 32: 738-47.
12. Armstrong DG, Boulton AJM, Bus SA. Diabetic foot ulcers and their recurrence. N Engl J Med 2017; 376: 2367-75.
13. Lim JZ, Ng NS, Thomas C. Prevention and treatment of diabetic foot ulcers. J R Soc Med 2017; 110: 104-9.
14. Lipsky BA, Senneville É, Abbas ZG, et al. Guidelines on the diagnosis and treatment of foot infection in persons with diabetes (IWGDF 2019 update). Diabetes Metab Res Rev 2020; 1: e3280.
15. Najafi B, Mishra R. Harnessing digital health technologies to remotely manage diabetic foot syndrome: a narrative review. Medicina (Kaunas) 2021; 57: 377.
16. Nair HKR. Wound management – what is new? Wound Treatment 2023; 20: 123-5.
17. Pasek J, Szajkowski S, Oleś P, et al. Local hyperbaric oxygen therapy in the treatment of diabetic foot ulcers. Int J Environ Res Public Health 2022; 19: 2-9.
18. Kushmakov R, Gandhi J, Seyam O, et al. Ozone therapy for diabetic foot. Med Gas Res 2018; 8: 111-5.
19. Dhamnaskar S, Gobbur N, Koranne M, et al. Prospective comparative observational study of safety and efficacy of topical ozone gas therapy in healing of diabetic foot ulcers versus only conventional wound management. Surg J 2021; 7: e226-36.
20. Zeng J, Lu J. Mechanisms of action involved in ozone-therapy in skin diseases. Int Immunopharmacol 2018; 56: 235-41.
21. Wen Q, Chen Q. An overview of ozone therapy for treating foot ulcers in patients with diabetes. Am J Med Sci 2020; 360: 112-9.
22. Izadi M, Jafari NJ, Hosseini MS, et al. Therapeutic effects of ozone in patients with diabetic foot ulcers: review of the literature. Biomedical Res 2017; 28: 7846-50.
23. Lu JY, Wang XQ, Fu ZB, et al. Topical ozone accelerates diabetic wound healing by promoting re-epithelialization through the activation of IGF1R-EGFR signaling. J Invest Dermatol 2023; 143: 2507-14.e6.
24. Kadir K, Syam Y, Yusuf S, et al. Ozone therapy on reduction of bacterial colonies and acceleration of diabetic foot ulcer healing. Home Health Now 2020; 38: 215-20.
25. Zanardi I, Borrelli E, Valacchi G, et al. Ozone: a multifaceted molecule with unexpected therapeutic activity. Curr Med Chem 2016; 23: 304-14.
26. Dhamodharan U, Viswanathan V, Krishnamoorthy E, et al. Genetic association of IL-6, TNF-a and SDF-1 polymorphisms with serum cytokine levels in diabetic foot ulcer Gene 2015; 565: 62-7.
27. Franzini M, Valdenassi L, Pandolfi S, et al. Comments on the optimal use of medical ozone in clinics versus the Ozone High Dose Therapy (OHT) approach. Transl Med Commun 2022; 7: 6-11.
28. Viebahn-Hänsler R, Sonia L, Fernández L, et al. Ozone in medicine: the low-dose ozone concept- guidelines and treatment strategies. Ozone Sci Engineer 2021; 34: 408-24.
29. Viebahn-Haensler R, Fernández L. Ozone in Medicine. The low-dose ozone concept and its basic biochemical mechanisms of action in chronic inflammatory diseases. Int J Mol Sci 2021; 22: 7890.
30. Brocklehurst P, Hoare Z. How to design a randomized controlled trial. Br Dent J 2017; 222: 721-6.
31. Smith NL, Wilson AL, Gandhi J, et al. Ozone therapy: an overview of pharmacodynamics, current research, and clinical utility. Med Gas Res 2017; 7: 212-9.
32. Senejko M, Pasek J, Szajkowski S, et al. Evaluation of the therapeutic efficacy of active specialistic medical dressings in the treatment of decubitus. Adv Dermatol Allergol 2021; 38: 75-9.
33. Kang H. Sample size determination and power analysis using the G*Power software. J Educ Eval Health 2021; 18: 17.
34. Crawford F, Nicolson DJ, Amanna AE, et al. Preventing foot ulceration in diabetes: systematic review and meta-analyses of RCT data. Diabetologia 2020; 63: 49-64.
35. Chen D, Wang M, Shang X, et al. Development and validation of an incidence risk prediction model for early foot ulcer in diabetes based on a high evidence systematic review and meta-analysis. Diabetes Res Clin Pract 2021; 180: 109040.
36. Boyko EJ, Zelnick LR, Braffett BH, et al. Risk of foot ulcer and lower-extremity amputation among participants in the Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study. Diabetes Care 2022; 45: 357-64.
37. Sun H, Heng H, Liu X, et al. Evaluation of the healing potential of short-term ozone therapy for the treatment of diabetic foot ulcers. Front Endocrinol 2024; 14: 1304034.
38. Fitzpatrick E, Holland OJ, Vanderlelie JJ. Ozone therapy for the treatment of chronic wounds: a systematic review. Int Wound J 2018; 15: 633-44.
39. Izadi M, Kheirjou R, Mohammadpour R, et al. Efficacy of comprehensive ozone therapy in diabetic foot ulcer healing. Diabetes Metab Syndr 2019; 13: 822-5.
40. Lavery LA, Ryan EC, Ahn J, et al. The infected diabetic foot: re-evaluating the Infectious Diseases Society of America diabetic foot infection classification. Clin Infect Dis 2020; 70: 1573-9.
41. Astasio-Picado Á, Babiano AÁ, López-Sánchez M, et al. Use of ozone therapy in diabetic foot ulcers. J Pers Med 2023; 13: 1439.
42. Mutluoglu M, Uzun G, Bennett M, et al. Poorly designed research does not help clarify the role of hyperbaric oxygen in the treatment of chronic diabetic foot ulcers. Diving Hyperb Med 2016; 46: 133-4.
Copyright: © 2024 Termedia Sp. z o. o. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
FEATURED PRODUCTS
BOOKS
• Atopowe Zapalenie Skóry • Choroby alergiczne w praktyce lekarza rodzinnego • Alergologia – kompendium
Termedia
About us Contact
Copyright notice Privacy policy Advertising policy Contact us
Quick links
Journals Books eBooks Events
© 2024 Termedia Sp. z o.o.
Developed by Bentus.